Clinical Trial Update: Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma. [Phase 1]

View source ↗

Summary

Phase I trial evaluating umbilical cord blood-derived natural killer (NK) cell therapy in children with high-risk, relapsed/refractory neuroblastoma; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• Umbilical Cord Blood Natural Killer (NK) Cell Therapy (Umbilical cord blood-derived natural killer cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Neuroblastoma | Phase 1 | Status: RECRUITING